,sentence,pubmed_id,content,label,labeler
0,"27 ||| Participants ||| 4.5 ||| Patients were eligible when they met the following inclusive criteria: patients with age ranging from 45 to 80 years; diagnosis of an acute cerebral infarction (CI) or TIA; greater than 50% stenosis of internal carotid artery (ICA), middle cerebral artery (MCA), vertebral artery (VA), basilar artery (BA), and posterior cerebral artery (PCA) alone or in combination; unsuitable or reluctance to perform stent implantation.",28072691,age ranging from 45 to 80 years,po.Age,奉捷
1,"27 ||| Participants ||| 4.5 ||| Patients were eligible when they met the following inclusive criteria: patients with age ranging from 45 to 80 years; diagnosis of an acute cerebral infarction (CI) or TIA; greater than 50% stenosis of internal carotid artery (ICA), middle cerebral artery (MCA), vertebral artery (VA), basilar artery (BA), and posterior cerebral artery (PCA) alone or in combination; unsuitable or reluctance to perform stent implantation.",28072691,diagnosis of an acute cerebral infarction (CI) or TIA,po.Disease,奉捷
2,"27 ||| Participants ||| 4.5 ||| Patients were eligible when they met the following inclusive criteria: patients with age ranging from 45 to 80 years; diagnosis of an acute cerebral infarction (CI) or TIA; greater than 50% stenosis of internal carotid arte (ICA), middle cerebral artery (MCA), vertebral artery (VA), basilar artery (BA), and posterior cerebral artery (PCA) alone or in combination; unsuitable or reluctance to perform stent implantation.缸ᘩ",28072691,greater than 50% stenosis of internal carotid artery (ICA),po.Disease,奉捷
3,"27 ||| Participants ||| 4.5 ||| Patients were eligible when they met the following inclusive criteria: patients with age ranging from 45 to 80 years; diagnosis of an acute cerebral infarction (CI) or TIA; greater than 50% stenosis of internal carotid arte (ICA), middle cerebral artery (MCA), vertebral artery (VA), basilar artery (BA), and posterior cerebral artery (PCA) alone or in combination; unsuitable or reluctance to perform stent implantation.缸ᘩ",28072691,middle cerebral artery (MCA),po.Disease,奉捷
4,"27 ||| Participants ||| 4.5 ||| Patients were eligible when they met the following inclusive criteria: patients with age ranging from 45 to 80 years; diagnosis of an acute cerebral infarction (CI) or TIA; greater than 50% stenosis of internal carotid arte (ICA), middle cerebral artery (MCA), vertebral artery (VA), basilar artery (BA), and posterior cerebral artery (PCA) alone or in combination; unsuitable or reluctance to perform stent implantation.缸ᘩ",28072691,vertebral artery (VA),po.Disease,奉捷
5,27 ||| Participants ||| 4.5 ||| Patients were eligible when they met the following inclusive criteria: patients with age ranging from 45 to 80 years; diagnosis of an acute cerebral infarction (CI) or TIA; greater than 50% stenosis of internal carotid arte,28072691, basilar artery (BA),po.Disease,奉捷
6,27 ||| Participants ||| 4.5 ||| Patients were eligible when they met the following inclusive criteria: patients with age ranging from 45 to 80 years; diagnosis of an acute cerebral infarction (CI) or TIA; greater than 50% stenosis of internal carotid arte,28072691,posterior cerebral artery (PCA) alone or in combination,po.Disease,奉捷
7,27 ||| Participants ||| 4.5 ||| Patients were eligible when they met the following inclusive criteria: patients with age ranging from 45 to 80 years; diagnosis of an acute cerebral infarction (CI) or TIA; greater than 50% stenosis of internal carotid arte,28072691,unsuitable or reluctance to perform stent implantation,po.Disease,奉捷
8,"63 ||| Statistical analysis ||| 6.8 ||| Among these patients, 66 received clopidogrel 50 mg plus aspirin, another 66 participants were treated using clopidogrel 75 mg plus aspirin, and the remaining 68 patients were treated using aspirin alone.",28072691,66,po.Size,奉捷
9,"63 ||| Statistical analysis ||| 6.8 ||| Among these patients, 66 received clopidogrel 50 mg plus aspirin, another 66 participants were treated using clopidogrel 75 mg plus aspirin, and the remaining 68 patients were treated using aspirin alone.",28072691,66 participants,po.Size,奉捷
10,"63 ||| Statistical analysis ||| 6.8 ||| Among these patients, 66 received clopidogrel 50 mg plus aspirin, another 66 participants were treated using clopidogrel 75 mg plus aspirin, and the remaining 68 patients were treated using aspirin alone.",28072691,68 patients,po.Size,奉捷
11,"63 ||| Statistical analysis ||| 6.8 ||| Among these patients, 66 received clopidogrel 50 mg plus aspirin, another 66 participants were treated using clopidogrel 75 mg plus aspirin, and the remaining 68 patients were treated using aspirin alone.",28072691,received clopidogrel 50 mg plus aspirin,i.Procedure,奉捷
12,"63 ||| Statistical analysis ||| 6.8 ||| Among these patients, 66 received clopidogrel 50 mg plus aspirin, another 66 participants were treated using clopidogrel 75 mg plus aspirin, and the remaining 68 patients were treated using aspirin alone.",28072691,were treated using clopidogrel 75 mg plus aspirin,i.Procedure,奉捷
13,"63 ||| Statistical analysis ||| 6.8 ||| Among these patients, 66 received clopidogrel 50 mg plus aspirin, another 66 participants were treated using clopidogrel 75 mg plus aspirin, and the remaining 68 patients were treated using aspirin alone.",28072691,were treated using aspirin alone,i.Procedure,奉捷
14,"38 ||| Participants ||| 4.16 ||| Patients meeting the inclusion criteria were randomly assigned (1:1:1) to receive aspirin alone (100 mg), or clopidogrel (50 mg) plus aspirin (100 mg), or clopidogrel (75 mg) plus aspirin (100 mg).",28072691,receive aspirin alone (100 mg),i.Procedure,奉捷
15,"38 ||| Participants ||| 4.16 ||| Patients meeting the inclusion criteria were randomly assigned (1:1:1) to receive aspirin alone (100 mg), or clopidogrel (50 mg) plus aspirin (100 mg), or clopidogrel (75 mg) plus aspirin (100 mg).",28072691,clopidogrel (50 mg) plus aspirin (100 mg),i.Procedure,奉捷
16,"38 ||| Participants ||| 4.16 ||| Patients meeting the inclusion criteria were randomly assigned (1:1:1) to receive aspirin alone (100 mg), or clopidogrel (50 mg) plus aspirin (100 mg), or clopidogrel (75 mg) plus aspirin (100 mg).",28072691,clopidogrel (75 mg) plus aspirin (100 mg),i.Procedure,奉捷
17,"66 ||| Statistical analysis ||| 6.11 ||| In all 200 patients, the median age was 62 years, and 79 (39.5%) patients were female.",28072691,200 patients,po.Size,奉捷
18,"66 ||| Statistical analysis ||| 6.11 ||| In all 200 patients, the median age was 62 years, and 79 (39.5%) patients were female.",28072691,the median age was 62 years,po.Age,奉捷
19,"66 ||| Statistical analysis ||| 6.11 ||| In all 200 patients, the median age was 62 years, and 79 (39.5%) patients were female.",28072691,79 (39.5%) patients were female,po.Size,奉捷
20,"66 ||| Statistical analysis ||| 6.11 ||| In all 200 patients, the median age was 62 years, and 79 (39.5%) patients were female.",28072691,female,po.Gender,奉捷
21,40 ||| Participants ||| 4.18 ||| Patients in clopidogrel (50 mg) plus aspirin (100 mg) group received clopidogrel at a dose of 50 mg/d and aspirin in a dose of 100 mg daily on day 1 through 90 days.,28072691, clopidogrel (50 mg) plus aspirin (100 mg) ,i.Procedure,奉捷
22,40 ||| Participants ||| 4.18 ||| Patients in clopidogrel (50 mg) plus aspirin (100 mg) group received clopidogrel at a dose of 50 mg/d and aspirin in a dose of 100 mg daily on day 1 through 90 days.,28072691,received clopidogrel at a dose of 50 mg/d,i.Procedure,奉捷
23,40 ||| Participants ||| 4.18 ||| Patients in clopidogrel (50 mg) plus aspirin (100 mg) group received clopidogrel at a dose of 50 mg/d and aspirin in a dose of 100 mg daily on day 1 through 90 days.,28072691,aspirin in a dose of 100 mg daily,i.Procedure,奉捷
24,41 ||| Participants ||| 4.19 ||| Cases in clopidogrel (75 mg) plus aspirin (100 mg) group received clopidogrel at a dose of 75 mg/d and aspirin at a dose of 100 mg/d on day 1 through 90 days.,28072691,clopidogrel (75 mg) plus aspirin (100 mg),i.Procedure,奉捷
25,41 ||| Participants ||| 4.19 ||| Cases in clopidogrel (75 mg) plus aspirin (100 mg) group received clopidogrel at a dose of 75 mg/d and aspirin at a dose of 100 mg/d on day 1 through 90 days.,28072691,received clopidogrel at a dose of 75 mg/d,i.Procedure,奉捷
26,41 ||| Participants ||| 4.19 ||| Cases in clopidogrel (75 mg) plus aspirin (100 mg) group received clopidogrel at a dose of 75 mg/d and aspirin at a dose of 100 mg/d on day 1 through 90 days.,28072691,aspirin at a dose of 100 mg/d,i.Procedure,奉捷
27,"7 |||  ||| 0.7 ||| Ischemic stroke occurred in 6 patients (9.1%) treated with 50 mg clopidogrel and aspirin, 6 patients (9.1%) receiving 75 mg clopidogrel and aspirin, whereas 19 patients (27.9%) in the aspirin group (aspirin alone vs copidogrel 50 mg plus aspirin; 95% confidence intervals 1.704-23.779, P < 0.05; aspirin alone vs copidogrel 75 mg plus aspirin; 95% confidence intervals 1.190-13.240, P < 0.05).",28072691,Ischemic stroke,i.SS,奉捷
28,"7 |||  ||| 0.7 ||| Ischemic stroke occurred in 6 patients (9.1%) treated with 50 mg clopidogrel and aspirin, 6 patients (9.1%) receiving 75 mg clopidogrel and aspirin, whereas 19 patients (27.9%) in the aspirin group (aspirin alone vs copidogrel 50 mg plus aspirin; 95% confidence intervals 1.704-23.779, P < 0.05; aspirin alone vs copidogrel 75 mg plus aspirin; 95% confidence intervals 1.190-13.240, P < 0.05).",28072691,treated with 50 mg clopidogrel and aspirin,i.Procedure,奉捷
29,"7 |||  ||| 0.7 ||| Ischemic stroke occurred in 6 patients (9.1%) treated with 50 mg clopidogrel and aspirin, 6 patients (9.1%) receiving 75 mg clopidogrel and aspirin, whereas 19 patients (27.9%) in the aspirin group (aspirin alone vs copidogrel 50 mg plus"": true}",28072691,receiving 75 mg clopidogrel and aspirin,i.Procedure,奉捷
30,"7 |||  ||| 0.7 ||| Ischemic stroke occurred in 6 patients (9.1%) treated with 50 mg clopidogrel and aspirin, 6 patients (9.1%) receiving 75 mg clopidogrel and aspirin, whereas 19 patients (27.9%) in the aspirin group (aspirin alone vs copidogrel 50 mg plu: 595, ""Success"": true}",28072691,aspirin alone vs copidogrel 50 mg plus aspirin,i.Procedure,奉捷
31,"7 |||  ||| 0.7 ||| Ischemic stroke occurred in 6 patients (9.1%) treated with 50 mg clopidogrel and aspirin, 6 patients (9.1%) receiving 75 mg clopidogrel and aspirin, whereas 19 patients (27.9%) in the aspirin group (aspirin alone vs copidogrel 50 mg plutrue}",28072691,aspirin alone vs copidogrel 75 mg plus aspirin,i.Procedure,奉捷
32,"4 |||  ||| 0.4 ||| We randomly assigned these patients to receive clopidogrel (75 or 50 mg) plus aspirin (100 mg) or aspirin (100 mg) once daily through 90 days, and followed them for 90 days.",28072691, receive clopidogrel (75 or 50 mg) plus aspirin (100 mg),i.Procedure,奉捷
33,"4 |||  ||| 0.4 ||| We randomly assigned these patients to receive clopidogrel (75 or 50 mg) plus aspirin (100 mg) or aspirin (100 mg) once daily through 90 days, and followed them for 90 days.",28072691,aspirin (100 mg) once daily,i.Procedure,奉捷
34,"79 ||| Statistical analysis ||| 6.24 ||| Both dual antiplatelet therapeutic approaches (copidogrel 50 mg plus aspirin, and copidogrel 75 mg plus aspirin) showed an obvious decrease in the recurrence of ischemic stroke (P < 0.05), comparing with that of the patients treated by aspirin alone.",28072691,showed an obvious decrease,o.Treatment,奉捷
35,"131 ||| Discussion ||| 7.44 ||| Taken together, our findings indicated that the use of 50 mg clopidogrel plus aspirin, and 75 mg clopidogrel plus aspirin was superior to aspirin alone in the aspect of reducing the incidence of ischemic stroke for patients with ICVD and intracranial and extracranial arteriostenosis.",28072691,was superior to aspirin alone,o.Treatment,奉捷
36,"10 |||  ||| 0.10 ||| Conclusion: Accordingly, 50 mg clopidogrel plus aspirin, and 75 mg clopidogrel plus aspirin were all superior to aspirin alone as stroke prevention in patients with cerebral infarction or transient ischemic attack combined with intracranial and extracranial arteriostenosis.",28072691,were all superior to aspirin alone,o.Treatment,奉捷
